About BioPact

This author has not yet filled in any details.
So far BioPact has created 2 entries.

BIOPACT’S MGMR® DRUG DELIVERY TECHNOLOGY SUCCEEDS IN TRANSPORTING CELL IMPERMEABLE PEPTIDES ACROSS CELL MEMBRANE TRIGGERING 100% CANCER CELL DEATH

Austin, TX (March 9, 2017) BioPact’s nanodelivery technology, MGMR®, demonstrated highly efficacious intracellular delivery of KLAKLAK, a pro-apoptotic peptide known to be cell membrane impermeable. When loaded on MGMR, KLAKLAK crossed the cell membrane of LNCaP human prostate cancer cells, triggering apoptosis in 100% of the cells in repeated studies.

KLAKLAK is a 1.5kD peptide […]

By |March 10th, 2017|News|0 Comments

BIOPACT ANNOUNCES MAXIMUM TOLERATED DOSE STUDY RESULTS FOR ITS MEDICAL GRADE MOLECULAR REBAR (MGMR®) NANOTECHNOLOGY

Cambridge, MA- (May 10, 2016) BioPact announced tolerability assessment data of its MGMR® (Medical Grade Molecular Rebar) nanotechnology. Study results indicated the maximum tolerated dose of MGMR is 180% higher than the therapeutically significant dose that was used in its previous successful safety study. Secondary endpoints indicated that multiple daily dosing was deemed well […]

By |May 11th, 2016|News|0 Comments